Modern pharmacological studies have shown that the activity of glutamate decarboxylase directly influences the metabolism of taurine and may cause the occurrence of cerebral palsy, which is associated with hyperbilirubinemia30, 31, 32. This evidence concerns the gene GLUL and cerebral palsy.